What Is Melatonin? (Sleep Hormone Mechanisms)
Most people think melatonin's only job is to make you drowsy at night. That's not quite right. Melatonin is the master regulator of circadian timing—it doesn't induce sleep directly, but signals to every tissue in your body that darkness has arrived and metabolic, hormonal, and neurological processes should shift accordingly. Without melatonin, your liver, kidneys, heart, and brain would each run on slightly different internal clocks, creating metabolic chaos.
We've worked with researchers studying chronobiology for years. The gap between what supplement labels claim and what melatonin actually does in the body is wider than most people realize.
What is melatonin and how does it work in the body?
Melatonin is a neurohormone synthesized primarily in the pineal gland from the amino acid tryptophan, released in response to darkness to regulate circadian rhythm, body temperature, immune function, and reproductive hormones by binding to MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN) of the hypothalamus. Peak secretion occurs between 2–4 AM, with levels typically ranging from 80–120 pg/mL during the day to 60–150 pg/mL at night in healthy adults.
Melatonin Synthesis and Regulation Pathways
Melatonin production follows a highly regulated four-step enzymatic pathway. The process begins with tryptophan, an essential amino acid obtained through diet. Tryptophan is first converted to 5-hydroxytryptophan (5-HTP) by tryptophan hydroxylase, then to serotonin by aromatic L-amino acid decarboxylase. Serotonin is converted to N-acetylserotonin by arylalkylamine N-acetyltransferase (AANAT)—the rate-limiting enzyme that determines melatonin output. Finally, hydroxyindole-O-methyltransferase (HIOMT) converts N-acetylserotonin into melatonin.
This pathway is controlled by the suprachiasmatic nucleus (SCN), a cluster of approximately 20,000 neurons located in the anterior hypothalamus directly above the optic chiasm. The SCN receives light input from specialized retinal ganglion cells containing melanopsin, a photopigment most sensitive to blue light at 480 nm wavelength. When melanopsin detects light, it sends inhibitory signals to the SCN, which suppresses AANAT activity in the pineal gland—effectively blocking melatonin synthesis during daylight hours.
As darkness falls and melanopsin stops detecting light, the SCN removes its inhibitory signal. The superior cervical ganglion releases norepinephrine, which binds to beta-adrenergic receptors on pinealocytes (pineal gland cells), activating AANAT and triggering melatonin synthesis within 2–3 hours of darkness onset. Melatonin is lipophilic, meaning it doesn't require vesicular transport—it diffuses directly through cell membranes into circulation immediately after synthesis.
Once in the bloodstream, melatonin has a short half-life of 20–50 minutes. It is rapidly metabolized in the liver by cytochrome P450 enzymes (primarily CYP1A2) into 6-hydroxymelatonin, which is then conjugated with sulfate or glucuronide and excreted in urine. This rapid clearance is why melatonin levels drop sharply after sunrise—the pineal gland stops producing it, and hepatic metabolism clears what remains within 1–2 hours.
Melatonin Receptor Mechanisms and Circadian Synchronization
Melatonin exerts its effects by binding to two G-protein-coupled receptors: MT1 (melatonin receptor 1A) and MT2 (melatonin receptor 1B). Both are located throughout the central nervous system and peripheral tissues, but their highest concentrations are in the SCN, where they regulate the master circadian clock.
MT1 receptor activation inhibits neuronal firing in the SCN, effectively silencing the wake-promoting signals that dominate during the day. This doesn't cause immediate sedation—it permits the transition to sleep by removing the active arousal mechanisms that keep you awake. Think of it as releasing the brake rather than stepping on the gas. MT2 receptor activation phase-shifts the circadian clock itself, advancing or delaying the timing of circadian rhythms depending on when melatonin is administered. This is why exogenous melatonin taken in the late afternoon can shift your circadian rhythm earlier (useful for eastward travel), while morning administration can delay it (useful for westward travel or delayed sleep phase disorder).
Beyond the SCN, melatonin receptors are found in the retina, cardiovascular system, immune cells, gastrointestinal tract, and reproductive organs. In the retina, melatonin regulates photoreceptor disc shedding and dopamine release, synchronizing visual sensitivity to the light-dark cycle. In the cardiovascular system, MT2 receptors mediate vasodilation, contributing to the nocturnal dip in blood pressure observed in healthy individuals—nighttime blood pressure typically drops 10–20% below daytime levels, a phenomenon impaired in shift workers and individuals with circadian misalignment.
Melatonin also regulates body temperature through hypothalamic thermoregulatory centers. Core body temperature drops approximately 0.3–0.5°C during the night, reaching its nadir around 4–5 AM—this decline is melatonin-dependent. When melatonin secretion is suppressed by bright light exposure at night, the normal temperature drop is blunted, which impairs sleep initiation. The vasodilatation in distal skin (hands and feet) that redistributes heat away from the core is mediated by melatonin signaling, which is why cold extremities can delay sleep onset.
Factors That Suppress or Enhance Melatonin Production
Light exposure is the dominant regulator of melatonin synthesis, but the relationship is dose-dependent and wavelength-specific. Blue light (450–480 nm) suppresses melatonin far more effectively than longer wavelengths—a 2011 study published in The Journal of Clinical Endocrinology & Metabolism found that 2 hours of blue-enriched light at 460 nm suppressed melatonin by 88%, while red light at 620 nm suppressed it by only 18%. This explains why electronic screens (smartphones, tablets, computer monitors) with blue-heavy LED backlighting are particularly disruptive to melatonin secretion when used within 2–3 hours of bedtime.
Lux intensity matters as well. Bright light above 1,000 lux almost completely suppresses melatonin within 30 minutes, while dim light below 50 lux has minimal effect. Standard indoor lighting ranges from 100–500 lux—sufficient to partially suppress melatonin if exposure occurs in the evening. A 2001 randomized controlled trial published in The Journal of Physiology demonstrated that even 200 lux of white light exposure for 90 minutes before bed reduced melatonin concentrations by 71% and delayed sleep onset by 85 minutes on average.
Age significantly impacts melatonin production. Peak melatonin output occurs during childhood and adolescence, with nighttime levels reaching 120–200 pg/mL. After age 40, nocturnal melatonin secretion declines by approximately 10% per decade—adults over 70 typically produce 50–60% less melatonin than young adults. This decline correlates with increased sleep fragmentation, earlier wake times, and reduced slow-wave sleep observed in older populations. The mechanism involves calcification of the pineal gland (accumulation of calcium phosphate deposits called corpora araceana), which reduces functional pinealocyte density.
Caffeine consumption affects melatonin indirectly through adenosine receptor antagonism. Adenosine accumulates during wakefulness and promotes sleep pressure by inhibiting wake-promoting neurons. Caffeine blocks adenosine receptors, reducing homeostatic sleep drive and indirectly suppressing melatonin onset. A 2015 double-blind study published in Science Translational Medicine found that 200 mg of caffeine (approximately one strong coffee) consumed 3 hours before habitual bedtime delayed melatonin onset by 40 minutes—comparable to the delay caused by bright light exposure.
Alcohol acutely suppresses melatonin secretion during the absorption phase. A study in Alcoholism: Clinical and Experimental Research showed that alcohol consumed in the evening reduced nocturnal melatonin levels by 15–19%, with suppression lasting 2–3 hours post-consumption. The mechanism involves disruption of pineal sympathetic innervation and altered serotonin metabolism, which reduces substrate availability for melatonin synthesis.
Melatonin: Supplement Formulation Comparison
| Formulation Type | Typical Dose Range | Time to Peak Plasma Concentration | Half-Life | Best Use Case | Professional Assessment |
|---|---|---|---|---|---|
| Immediate-release tablet/capsule | 0.3–5 mg | 40–60 minutes | 20–50 minutes | Sleep onset difficulty, jet lag, circadian phase advance | Most studied formulation; effective for sleep initiation but does not maintain levels through the night—suitable for people who fall asleep easily once drowsy |
| Sustained-release formulation | 1–10 mg | 60–90 minutes | Extended 3–4 hours | Sleep maintenance insomnia, middle-of-night awakenings | Maintains plasma levels longer than immediate-release; useful for individuals who wake frequently after initial sleep onset |
| Sublingual tablet/liquid | 0.5–3 mg | 15–30 minutes | 20–50 minutes | Rapid onset needed, first-pass metabolism concerns | Bypasses hepatic first-pass metabolism, achieving faster onset; ideal for situational use when quick circadian signaling is desired |
| Melatonin with Pinealon | Variable dosing | Depends on formulation | Variable | Neuroprotection research combined with circadian support | Pinealon is a pineal gland peptide bioregulator studied for neurological and circadian applications; used in research settings to explore synergistic mechanisms |
Key Takeaways
- Melatonin is synthesized from tryptophan through a four-step enzymatic pathway regulated by the suprachiasmatic nucleus (SCN) in response to light and darkness detected by melanopsin-containing retinal ganglion cells.
- MT1 receptors inhibit neuronal firing in the SCN to remove wake-promoting signals, while MT2 receptors phase-shift the circadian clock itself, enabling entrainment to environmental light-dark cycles.
- Blue light at 460–480 nm suppresses melatonin secretion by 88% after 2 hours of exposure, far exceeding suppression caused by longer-wavelength red or amber light.
- Melatonin has a plasma half-life of 20–50 minutes and is metabolized primarily by hepatic CYP1A2 enzymes into 6-hydroxymelatonin, which is excreted renally.
- Nocturnal melatonin secretion declines by approximately 10% per decade after age 40 due to pineal gland calcification, correlating with age-related sleep disturbances.
- Melatonin regulates not only sleep-wake cycles but also body temperature (nocturnal core temperature drop of 0.3–0.5°C), blood pressure (10–20% nocturnal dip), immune function, and retinal photoreceptor activity.
What If: Melatonin Scenarios
What If I Take Melatonin but Still Can't Fall Asleep?
Check your dosing timing and light environment first—melatonin must be taken 30–90 minutes before desired sleep onset, and bright light exposure within that window will counteract its effects entirely. If you take melatonin then immediately look at a bright screen or sit in a well-lit room, melanopsin-mediated suppression overrides the exogenous dose. The effective dose for circadian signaling is much lower than most supplements provide—physiological replacement is 0.3–0.5 mg, while typical supplements contain 3–10 mg. Higher doses don't produce proportionally stronger effects and may cause next-day grogginess due to residual receptor occupancy. If low-dose melatonin timed correctly still doesn't improve sleep latency, the issue may not be circadian misalignment but rather hyperarousal, sleep apnea, or another sleep disorder that melatonin doesn't address.
What If My Melatonin Levels Are Naturally Low?
If salivary or urinary melatonin metabolite testing confirms low nocturnal melatonin (common in shift workers, older adults, or individuals with pineal calcification), exogenous supplementation can restore circadian signaling. Use dim-light melatonin onset (DLMO) testing to determine your natural melatonin rise time—supplementation should be timed 2–3 hours before this point to phase-advance your rhythm, or at your habitual bedtime if maintaining current timing. Low melatonin without circadian misalignment symptoms may not require intervention—some individuals maintain normal sleep with lower melatonin levels due to compensatory mechanisms in other circadian pathways. Address light hygiene first: eliminate blue light exposure after sunset, increase daytime bright light (ideally 10,000+ lux within 1 hour of waking), and maintain consistent sleep-wake schedules to optimize endogenous production before adding supplements.
What If I'm Using Melatonin for Jet Lag?
The timing of melatonin administration determines whether it advances or delays your circadian rhythm. For eastward travel (requiring phase advance), take 0.5–3 mg melatonin in the late afternoon or early evening at your destination—this signals your SCN to shift your clock earlier. For westward travel (requiring phase delay), melatonin is less effective because taking it in the early morning (when needed to delay the clock) conflicts with light exposure and is often impractical. Instead, focus on timed bright light exposure: morning light delays your rhythm, evening light advances it. Combine melatonin with strategic light exposure for maximum entrainment speed—most people require 1 day of adjustment per 1–1.5 time zones crossed when using both tools together. Avoid high-dose melatonin (above 5 mg) for jet lag—it increases next-day sedation without improving circadian adjustment.
What If I'm Considering Long-Term Melatonin Use?
Melatonin does not cause physiological dependence or suppress endogenous production when used at replacement doses (0.3–3 mg). Long-term studies spanning 6–24 months show no tolerance development or withdrawal symptoms upon discontinuation. However, chronic high-dose use (10+ mg nightly) may desensitize MT1 and MT2 receptors, reducing responsiveness over time. For sustained use, stick to the lowest effective dose and prioritize circadian hygiene: consistent sleep-wake times, morning bright light exposure, evening light restriction, and temperature regulation (cool bedroom at 16–19°C). If you've used melatonin nightly for months and find it no longer works, take a 1–2 week washout period to restore receptor sensitivity, then resume at a lower dose. Long-term safety data for melatonin is robust—meta-analyses of randomized controlled trials show no serious adverse events with continuous use up to 2 years—but it remains a tool to support circadian alignment, not a substitute for addressing underlying causes of sleep disruption.
The Physiological Truth About Melatonin
Here's the honest answer: melatonin supplements are wildly overused for conditions they don't treat. If your sleep problem is anxiety, restless legs, sleep apnea, or chronic pain, melatonin won't fix it—those are arousal or structural sleep disorders, not circadian timing disorders. Melatonin works for delayed sleep phase disorder, jet lag, shift work adjustment, and age-related circadian rhythm weakening. It does not work as a general sedative.
The dose matters more than the marketing suggests. Most supplements contain 3–10 mg, but the physiological dose that matches natural nighttime secretion is 0.3–0.5 mg. Higher doses saturate receptors without additional benefit and increase the likelihood of next-day grogginess, vivid dreams, and receptor desensitization with chronic use. A 2001 study published in Sleep Medicine Reviews found that 0.3 mg was as effective as 3 mg for sleep onset and circadian phase-shifting, with fewer side effects.
The supplement industry's quality control is inconsistent at best. A 2017 analysis published in the Journal of Clinical Sleep Medicine tested 31 melatonin supplements and found actual melatonin content ranged from −83% to +478% of labeled dose—meaning some products contained almost no melatonin while others had nearly five times the stated amount. Lot-to-lot variability within the same brand was common. If using melatonin for research or therapeutic purposes, choose products with third-party testing (USP, NSF, or ConsumerLab certification) to verify content accuracy.
Melatonin is not a sleep aid in the pharmaceutical sense—it's a chronobiotic, meaning it shifts or reinforces circadian timing. If your circadian rhythm is already aligned with your desired sleep schedule and you still can't sleep, adding melatonin won't help. Fix your light environment, caffeine timing, and sleep hygiene first. Use melatonin only when the problem is demonstrably circadian.
Melatonin remains one of the most valuable tools in chronobiology and sleep medicine when used correctly—timed appropriately, dosed physiologically, and targeted at circadian misalignment rather than insomnia broadly defined. The difference between effective and ineffective use comes down to understanding what melatonin actually does: it tells your body what time it is, not whether to be asleep or awake. That distinction matters more than most people realize.
At Real Peptides, we focus on providing research-grade compounds with verified purity for biological research applications. Our catalog includes peptides like Pinealon, a pineal gland bioregulator studied for its potential neuroprotective and circadian-supportive properties, and Epithalon, a tetrapeptide investigated for its effects on melatonin secretion and circadian rhythm regulation in aging models. You can explore our full range of high-purity peptides at Real Peptides to find the right tools for your research into circadian biology, neuroprotection, and beyond.
The most common mistake with melatonin isn't the supplement itself—it's expecting it to solve a problem it was never designed to address.
Frequently Asked Questions
How does melatonin regulate sleep if it doesn’t directly cause drowsiness?
▼
Melatonin signals darkness to the suprachiasmatic nucleus (SCN) in the hypothalamus, which then removes wake-promoting neuronal activity and lowers core body temperature by 0.3–0.5°C—these changes permit sleep onset by eliminating active arousal mechanisms rather than inducing sedation directly. MT1 receptor activation inhibits SCN firing, while MT2 receptor activation phase-shifts the circadian clock to align with environmental light-dark cycles. This is why melatonin works for circadian misalignment (jet lag, shift work, delayed sleep phase) but not for anxiety-driven insomnia or structural sleep disorders.
Can I become dependent on melatonin supplements if I take them every night?
▼
No—melatonin does not suppress endogenous production or cause physiological dependence when used at replacement doses of 0.3–3 mg. Long-term studies spanning 6–24 months show no tolerance development or withdrawal symptoms upon discontinuation. However, chronic high-dose use (10+ mg nightly) may desensitize MT1 and MT2 receptors over time, reducing responsiveness. If effectiveness declines after months of nightly use, a 1–2 week washout period can restore receptor sensitivity before resuming at a lower dose.
What is the correct dose of melatonin for circadian phase-shifting versus sleep onset?
▼
Physiological replacement doses of 0.3–0.5 mg are as effective as 3–5 mg for circadian phase-shifting and sleep onset, according to randomized trials published in ‘Sleep Medicine Reviews’. Higher doses (5–10 mg) saturate receptors without additional benefit and increase next-day grogginess and vivid dreams. For jet lag or shift work, 0.5–3 mg taken 30–90 minutes before desired sleep time is sufficient. Most over-the-counter supplements contain 3–10 mg—far above the physiological dose—due to marketing rather than evidence.
Why does melatonin production decline with age and what are the consequences?
▼
Nocturnal melatonin secretion declines by approximately 10% per decade after age 40 due to pineal gland calcification—accumulation of calcium phosphate deposits (corpora araceana) reduces functional pinealocyte density. Adults over 70 produce 50–60% less melatonin than young adults, correlating with increased sleep fragmentation, earlier wake times, reduced slow-wave sleep, and blunted nocturnal blood pressure dipping. Exogenous low-dose melatonin (0.3–1 mg) can partially restore circadian signaling in older adults with documented low melatonin levels.
How does blue light exposure suppress melatonin more than other wavelengths?
▼
Blue light at 460–480 nm activates melanopsin photopigment in retinal ganglion cells far more effectively than longer wavelengths—2 hours of blue-enriched light suppresses melatonin by 88%, while red light at 620 nm suppresses it by only 18%, according to research published in ‘The Journal of Clinical Endocrinology & Metabolism’. Melanopsin sends inhibitory signals to the suprachiasmatic nucleus (SCN), which blocks arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme for melatonin synthesis. This is why LED screens with blue-heavy backlighting are particularly disruptive when used within 2–3 hours of bedtime.
How does melatonin compare to prescription sleep medications for treating insomnia?
▼
Melatonin is a chronobiotic that shifts or reinforces circadian timing—it works for delayed sleep phase disorder, jet lag, and circadian misalignment but not for hyperarousal-driven insomnia, sleep apnea, or restless legs syndrome. Prescription hypnotics (benzodiazepines, Z-drugs, orexin antagonists) directly enhance GABAergic inhibition or block wake-promoting pathways, inducing sedation regardless of circadian alignment. Meta-analyses show melatonin reduces sleep latency by 7–12 minutes on average versus 20–40 minutes for prescription hypnotics, but melatonin has no risk of dependence, tolerance, or next-day cognitive impairment when dosed physiologically (0.3–3 mg).
What is the optimal timing for melatonin when traveling across multiple time zones?
▼
For eastward travel (requiring circadian phase advance), take 0.5–3 mg melatonin in the late afternoon or early evening at your destination—this signals your SCN to shift your clock earlier. For westward travel (requiring phase delay), melatonin is less effective because administration would need to occur in the early morning, which conflicts with light exposure. Combine melatonin with strategic bright light: morning light at destination for westward travel, evening light avoidance for eastward travel. Most people require 1 day of adjustment per 1–1.5 time zones crossed when using both timed melatonin and light exposure together.
Does melatonin interact with medications metabolized by cytochrome P450 enzymes?
▼
Yes—melatonin is metabolized primarily by CYP1A2, and to a lesser extent CYP2C19, in the liver. Medications that inhibit CYP1A2 (fluvoxamine, ciprofloxacin, verapamil) can increase melatonin plasma levels and prolong its half-life, potentially causing next-day sedation or grogginess. Conversely, CYP1A2 inducers (smoking, chargrilled meat, omeprazole) may reduce melatonin bioavailability. Melatonin itself does not significantly inhibit or induce cytochrome P450 enzymes at physiological doses, so it is unlikely to alter the metabolism of other medications when used at 0.3–3 mg.
What are the non-sleep-related physiological functions of melatonin in the body?
▼
Melatonin regulates immune function by modulating cytokine production (enhancing interleukin-2 and interferon-gamma while suppressing pro-inflammatory interleukin-6), acts as a direct free radical scavenger with antioxidant activity in mitochondria, controls retinal photoreceptor disc shedding and dopamine release to synchronize visual sensitivity, mediates nocturnal blood pressure dipping (10–20% drop via MT2 receptor-mediated vasodilation), and regulates reproductive hormone secretion by modulating gonadotropin-releasing hormone (GnRH) pulsatility in the hypothalamus. These functions extend far beyond sleep and explain why circadian misalignment has systemic metabolic and cardiovascular consequences.
How accurate is the melatonin content in over-the-counter supplements?
▼
A 2017 study published in the ‘Journal of Clinical Sleep Medicine’ analyzed 31 melatonin supplements and found actual melatonin content ranged from −83% to +478% of the labeled dose—some products contained almost no melatonin while others had nearly five times the stated amount. Lot-to-lot variability within the same brand was common, and 26% of supplements contained detectable serotonin, a controlled precursor that should not be present. For research or therapeutic use, choose products with third-party certification (USP, NSF, ConsumerLab) to verify content accuracy and purity.
Why do some people experience vivid dreams or nightmares when taking melatonin?
▼
Melatonin increases REM (rapid eye movement) sleep duration and intensity, particularly during the second half of the night when REM cycles naturally lengthen. Higher doses (5–10 mg) amplify this effect, leading to more vivid, emotionally intense, or bizarre dreams due to prolonged REM periods. The mechanism involves MT2 receptor-mediated modulation of acetylcholine release in the pons and basal forebrain—regions critical for REM generation. Reducing the dose to 0.3–1 mg typically eliminates this side effect while preserving circadian benefits. Vivid dreams are not harmful but can be disruptive for some users.
Can melatonin be used therapeutically for conditions other than sleep disorders?
▼
Emerging research suggests melatonin may have therapeutic applications beyond circadian regulation, including antioxidant neuroprotection in traumatic brain injury and stroke models, immune modulation in sepsis and autoimmune conditions, and metabolic regulation in non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. A 2020 meta-analysis in ‘Diabetes Research and Clinical Practice’ found melatonin supplementation reduced fasting glucose and insulin resistance markers in diabetic patients. However, these applications remain investigational—most evidence comes from animal models or small-scale human trials. Melatonin’s anti-inflammatory, antioxidant, and mitochondrial-protective properties are driving ongoing research in oncology, neurodegenerative disease, and metabolic syndrome.